Media Center

PUBLICATIONS

hands typing on computer

Development of Protective Immunity in New Zealand White Rabbits Challenged with Bacillus anthracis Spores and Treated with Antibiotics and Obiltoxaximab, a Monoclonal Antibody against Protective Antigen

Lisa N. Henning, Sarah Carpenter, Gregory V. Stark, Natalya V. Serbina

Antimicrobial Agents and Chemotherapy Jan 2018, 62 (2) e01590-17; DOI: 10.1128/AAC.01590-17

Animal-to-Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule

Nagy, C., Mondick, J., Serbina, N., Casey, L., Carpenter, S., French, J. and Guttendorf, R.

Clinical And Translational Science. Volume 10, Issue 1, January 2017, Pages 12–19. doi:10.1111/cts.12433

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity

Brent J. Yamamoto, Annette M. Shadiack, Sarah Carpenter, Daniel Sanford, Lisa N. Henning, Edward O’Connor, Nestor Gonzales, John Mondick, Jonathan French, Gregory V. Stark, Alan C. Fisher, Leslie S. Casey and Natalya V. Serbina

Antimicrob. Agents Chemother. October 2016 vol. 60 no. 10 5787-5795

Obiltoxaximab Prevents Disseminated Bacillus anthracis Infection and Improves Survival during Pre-and Postexposure Prophylaxis in Animal Models of Inhalational Anthrax

Brent J. Yamamoto, Annette M. Shadiack, Sarah Carpenter, Daniel Sanford, Lisa N. Henning, Nestor Gonzales, Edward O’Connor, Leslie S. Casey and Natalya V. Serbina

Antimicrob. Agents Chemother. October 2016 vol. 60 no. 10 5796-5805

Pharmacokinetics and Tolerability of Obiltoxaximab: A Report of 5 Healthy Volunteer Studies

Christa F. Nagy, PhD, Timothy S. Leach, MD, MPH, Joseph H. Hoffman, MD, Arthur Czech, BS, Sarah E. Carpenter, PhD, Robert Guttendorf, RPh, PhD

Clinical Therapeutics/September 2016 Volume 38, Issue 9, Pages 2083-2097

Posters, 2016 ASM Biodefense and Emerging Diseases Research Meeting Presentations, February 8-10, 2016

Animal to Human Dose Translation under the Animal Rule – Obiltoxaximab (ETI-204) Case Study
C. Nagy1, J. Mondick2, N. Serbina1, L. Casey1and R. Guttendorf3
1Elusys Therapeutics Inc., Pine Brook, NJ; 2Metrum Research Group LLC, Tariffville, CT; 3Aclairo Pharmaceutical Development Group Inc., Vienna, VA

Safety, Pharmacokinetics and Immunogenicity of Intramuscular (IM) Administration of Obiltoxaximab (ETI-204) to Healthy Humans
A.Czech1, J. Mondick2, R. Guttendorf3, A. King4 and C. Nagy1
1Elusys Therapeutics Inc., Pine Brook, NJ; 2Metrum Research Group LLC, Tariffville, CT; 3Aclairo Pharmaceutical Development Group Inc., Vienna, VA; 4Covance Clinical Research Unit, Inc., Dallas, TX

The use of meta-analysis approach to demonstrate added benefit of Obiltoxaximab (ETI-204) in treatment of inhalational anthrax
N. Serbina1, G. Stark2, A. Fisher3, L. Casey1, R. Slay4, and R. Conrad1
1Elusys Therapeutics, Inc., Pine Brook NJ, 2Battelle BioMed. Res. Ctr., Columbus, OH, 3BDM Consulting, Inc., 4NIAID/NIH

Presented at 2015 ASM Biodefense and Emerging Diseases Research Meeting, Washington, DC, February 9-11, 2015

Obiltoxaximab (ETI-204) Efficacy across a Spectrum of Disease Severity in a Trigger-to-Treat Cynomolgus Monkey Inhalational Aerosol Challenge Model of Anthrax
B. Yamamoto1, N. Serbina1, S. Carpenter1, D. Sanford2, G. Stark2, A. Shadiack1,3, and L. Casey1
1Elusys Therapeutics, Inc., Pine Brook NJ, 2Battelle, Columbus OH, 3Currently at Therapeutics MD, Inc

You are now leaving www.Elusys.com, a site provided by Elusys Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. Elusys Therapeutics, Inc. does not endorse and/or influence the content found on websites not owned/operated by Elusys Therapeutics, Inc.

You are now leaving www.Elusys.com, a site provided by Elusys Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. Elusys Therapeutics, Inc. does not endorse and/or influence the content found on websites not owned/operated by Elusys Therapeutics, Inc.

You are now leaving www.Elusys.com, a site provided by Elusys Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. Elusys Therapeutics, Inc. does not endorse and/or influence the content found on websites not owned/operated by Elusys Therapeutics, Inc.

You are now leaving www.Elusys.com, a site provided by Elusys Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. Elusys Therapeutics, Inc. does not endorse and/or influence the content found on websites not owned/operated by Elusys Therapeutics, Inc.

You are now leaving www.Elusys.com, a site provided by Elusys Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. Elusys Therapeutics, Inc. does not endorse and/or influence the content found on websites not owned/operated by Elusys Therapeutics, Inc.

You are now leaving www.Elusys.com, a site provided by Elusys Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. Elusys Therapeutics, Inc. does not endorse and/or influence the content found on websites not owned/operated by Elusys Therapeutics, Inc.

You are now leaving www.Elusys.com, a site provided by Elusys Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. Elusys Therapeutics, Inc. does not endorse and/or influence the content found on websites not owned/operated by Elusys Therapeutics, Inc.

You are now leaving www.Elusys.com, a site provided by Elusys Therapeutics, Inc. This link will take you to a website to which this Privacy Policy does not apply. We encourage you to read the Privacy Policy of every website you visit. Elusys Therapeutics, Inc. does not endorse and/or influence the content found on websites not owned/operated by Elusys Therapeutics, Inc.